Morgan Stanley’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677M Sell
7,993,002
-1,938,300
-20% -$156M 0.04% 454
2026
Q1
$831M Buy
9,931,302
+999,488
+11% +$75.3M 0.05% 358
2025
Q4
$599M Buy
8,931,814
+122,308
+1% +$7.91M 0.04% 469
2025
Q3
$596M Buy
8,809,506
+646,335
+8% +$46.8M 0.04% 461
2025
Q2
$608M Buy
8,163,171
+336,012
+4% +$22.4M 0.04% 443
2025
Q1
$493M Buy
7,827,159
+203,989
+3% +$12.6M 0.04% 467
2024
Q4
$434M Sell
7,623,170
-146,523
-2% -$8.66M 0.03% 526
2024
Q3
$457M Sell
7,769,693
-444,176
-5% -$24.3M 0.03% 502
2024
Q2
$443M Sell
8,213,869
-4,613,795
-36% -$254M 0.03% 490
2024
Q1
$740M Buy
12,827,664
+4,158,714
+48% +$215M 0.06% 302
2023
Q4
$415M Sell
8,668,950
-606,638
-7% -$28.9M 0.04% 469
2023
Q3
$475M Sell
9,275,588
-61,631
-0.7% -$3.26M 0.05% 376
2023
Q2
$535M Buy
9,337,219
+437,176
+5% +$25.5M 0.05% 347
2023
Q1
$537M Sell
8,900,043
-552,897
-6% -$33.8M 0.06% 326
2022
Q4
$556M Buy
9,452,940
+746,972
+9% +$47.3M 0.06% 312
2022
Q3
$498M Buy
8,705,968
+533,450
+7% +$31.1M 0.07% 275
2022
Q2
$442M Buy
8,172,518
+3,058,762
+60% +$178M 0.06% 326
2022
Q1
$294M Buy
5,113,756
+67,503
+1% +$3.45M 0.04% 411
2021
Q4
$239M Sell
5,046,253
-665,644
-12% -$30.3M 0.03% 499
2021
Q3
$240M Buy
5,711,897
+1,075,445
+23% +$46.5M 0.03% 464
2021
Q2
$206M Buy
4,636,452
+975,906
+27% +$45.1M 0.03% 535
2021
Q1
$171M Sell
3,660,546
-669,558
-15% -$29.6M 0.03% 537
2020
Q4
$168M Buy
4,330,104
+4,993
+0.1% +$178K 0.03% 529
2020
Q3
$125M Buy
4,325,111
+2,531,885
+141% +$71.3M 0.02% 516
2020
Q2
$48M Sell
1,793,226
-66,458
-4% -$1.73M 0.01% 854
2020
Q1
$43.7M Sell
1,859,684
-428,711
-19% -$11.8M 0.01% 793
2019
Q4
$67.6M Sell
2,288,395
-1,985,563
-46% -$52.6M 0.02% 778
2019
Q3
$120M Buy
4,273,958
+691,632
+19% +$20M 0.03% 499
2019
Q2
$106M Buy
+3,582,326
New +$96.4M 0.03% 544

Other funds holding CTVA

Morgan Stanley's CTVA Position: Q2 2026 in Review

Morgan Stanley reduced its Corteva (CTVA) stake by 20% in Q2 2026, selling an estimated $156M and leaving 7,993,002 shares worth $677M. The position accounts for 0.04% of the portfolio, ranked #454.

Morgan Stanley first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $831M in Q1 2026. 1,489 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Morgan Stanley held 7,993,002 shares of Corteva worth $677M as of Q2 2026.
  • Morgan Stanley sold 1,938,300 Corteva shares in Q2 2026, an estimated $156M.
  • Corteva made up 0.04% of Morgan Stanley's portfolio in Q2 2026, its #454 holding.
  • Morgan Stanley first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
  • Morgan Stanley's Corteva position peaked at $831M in Q1 2026.
  • 1,489 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.